Currently out of the existing stock ratings of Sezgi Oezener, 5 are a HOLD (71.43%), 1 are a SELL (14.29%), 1 are a BUY (14.29%).

Sezgi Oezener

Work Performance Price Targets & Ratings Chart

Analyst Sezgi Oezener works at HSBC with a stock forecast success ratio of 16.67% fulfilled within 3 days on average.

Sezgi Oezener’s has documented 12 price targets and ratings displayed on 4 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 24-Nov-2023.

Wall Street Analyst Sezgi Oezener

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 10/25/2022. The price target of $11.9 was fulfilled within 9 days with a profit of $0.53 (4.26%) receiving and performance score of 4.74.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SE Sea Ltd FSNUY Fresenius SE KGaA ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

34

4 months 26 days ago

0/2 (0%)

$15.46 (83.39%)

36.47

$17.57 (92.96%)

50.57

5 months 10 days ago

4/15 (26.67%)

$19.39 (113.52%)

137

Sell

29.84

$10.94 (57.88%)

33.99

5 months 16 days ago

3/15 (20%)

$12.41 (71.20%)

116

40.12

$21.22 (112.28%)

44.25

5 months 30 days ago

0/5 (0%)

$22.47 (127.31%)

Hold

24

$5.1 (26.98%)

28

6 months 8 days ago

4/9 (44.44%)

$6.73 (38.97%)

153

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Sezgi Oezener is most bullish on?

Potential upside of $0 has been obtained for FMS (FRESENIUS MEDICAL CARE)

What Year was the first public recommendation made by Sezgi Oezener?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?